Insulet PODD
NASDAQ PODD
$134.58 -3.34 (-2.42%)
As of: Sep 10, 2026 · 2:54 PM EDT

Insulet (PODD) Non-Current Debt (2010 - 2026)

Insulet's (PODD) quarterly Non-Current Debt came in at $929.5 million in Q2 2026, down 1.01% on a YoY basis from $939.0 million in Q2 2025, and little changed quarter-over-quarter from $929.5 million in Q1 2026.

Analysis

Insulet (PODD) Non-Current Debt (2010 - 2026) Analysis & Trends

Insulet (PODD) has reported Non-Current Debt for 17 consecutive years, with $929.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non-Current Debt fell 1.01% year-over-year to $929.5 million; the trailing twelve-month figure through Jun 2026 stood at $929.5 million (down 1.01% YoY), and the FY2025 full-year result was $930.8 million, down 28.18% from the prior year.
  • Non-Current Debt was little changed at $929.5 million in Q2 2026 per PODD's latest filing, from $929.5 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $1.6 billion in Q1 2025 and bottomed at $929.5 million in Q1 2026.
  • Historically, Non-Current Debt has averaged $1.3 billion across 5 years, with a median of $1.4 billion in 2023.
  • The sharpest annual moves came in 2022 and 2026: Non-Current Debt soared 32.69% in 2022, then slumped 42.35% in 2026.
  • Over 5 years, Non-Current Debt stood at $1.4 billion in 2022, then slipped by 0.57% to $1.4 billion in 2023, then dropped by 5.14% to $1.3 billion in 2024, then declined by 28.18% to $930.8 million in 2025, then retreated by 0.14% to $929.5 million in 2026.
  • According to Business Quant data, Non-Current Debt over the past three periods registered $929.5 million, $929.5 million, and $930.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 180.76 Bn 175.16 Bn 7.27 Bn 29.60 Bn
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn -
3 Medtronic 117.20 Bn 108.39 Bn 6.34 Bn 25.62 Bn
4 Stryker 104.01 Bn 100.53 Bn 4.50 Bn 14.19 Bn
5 Boston Scientific 63.51 Bn 62.97 Bn 3.85 Bn 10.92 Bn
6 Edwards Lifesciences 49.80 Bn 45.55 Bn 1.35 Bn 598.70 Mn
7 Alcon 33.03 Bn 31.58 Bn 1.68 Bn -1.00 Mn
8 Dexcom 32.18 Bn 30.23 Bn 830.00 Mn -
9 Steris 20.71 Bn 20.23 Bn 684.20 Mn 1.65 Bn
10 Insulet 9.35 Bn 8.82 Bn 562.60 Mn 929.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 929.50 Mn
Mar 31, 2026 929.50 Mn
Dec 31, 2025 930.80 Mn
Sep 30, 2025 934.90 Mn
Jun 30, 2025 939.00 Mn
Mar 31, 2025 1.61 Bn
Dec 31, 2024 1.30 Bn
Sep 30, 2024 1.36 Bn
Jun 30, 2024 1.36 Bn
Mar 31, 2024 1.36 Bn
Dec 31, 2023 1.37 Bn
Sep 30, 2023 1.37 Bn
Jun 30, 2023 1.40 Bn
Mar 31, 2023 1.40 Bn
Dec 31, 2022 1.37 Bn
Sep 30, 2022 1.41 Bn
Jun 30, 2022 1.41 Bn
Mar 31, 2022 1.42 Bn
Dec 31, 2021 1.27 Bn
Sep 30, 2021 1.29 Bn